Newsletter | November 18, 2026

11.18.26 -- Is It Time To Rethink Your Protein Expression Strategy?

Overview Of Recombinant Protein Expression Systems

Which protein expression system is the best fit for your protein target? Compare expression hosts based on protein complexity, scalability, cost, quality, and commercial production needs.

 

Building A Resilient Supply Chain For Complex IVD Reagents (Diagnostic Proteins)

Securing a reliable supply of complex antigens and enzymes can be just as important as assay performance. Explore considerations for bypassing production bottlenecks, improving lot-to-lot consistency, and achieving rapid scalability.

 

Transgenic Fruit Flies Vs. Cell Lines: Eliminating Bioreactor Bottlenecks

Traditional cell line development can introduce challenges as manufacturing scales. See how transgenic fruit flies offer an alternative approach to stability, consistency, and bioreactor constraints.

 

Understanding Glycosylation Patterns In Insect-Based Expression Systems

Proper glycosylation is critical when selecting an expression platform. Explore how transgenic Drosophila produces functional glycosylated Erythropoietin as a case study and compare N-glycosylation patterns between conventional systems.

 

VIDEO FEATURE

Inside Look At A Fruit Fly Biomanufacturing Facility | Future Fields Instar 1.0 Biofactory

Step inside a fruit fly-based biomanufacturing facility for a closer look at how this alternative production model supports protein manufacturing from development through commercial scale.

 

EARLY ACCESS

 

 

Standard cell-free platforms often struggle with complex protein folding and post-translational modifications. We are currently developing a next-generation eukaryotic cell-free platform to address these bottlenecks. Connect with our scientific team to discuss technical parameters or join our early access list. Sign up here.